22nd Century Group Inc. said Wednesday it has commenced retail production of the first cartons of the very-low-nicotine branded VLN King and VLN Menthol King cigarettes.
Read articles from United States of America
February 09, 2022 by jamanetwork.com
Treatment of Tobacco Smoking
More deaths in the US are attributed to cigarette smoking each year than to any other preventable cause. Approximately 34 million people and an estimated 14% of adults in the US smoke cigarettes. If they stopped smoking, they could reduce their risk of tobacco-related morbidity and mortality and potentially gain up to 10 years of life. Tobacco smoking is a chronic disorder maintained by physical nicotine dependence and learned behaviors. Approximately 70% of people who smoke cigarettes want to quit smoking. However, individuals who attempt to quit smoking make an average of approximately 6 quit attempts before achieving long-term abstinence. [...]
February 08, 2022 by upi.com
Marijuana use high among adolescent, teen, young adult vapers, study finds
More than one-third of adolescents and half of teens and young adults who vape use the devices for marijuana, a study published Monday by JAMA Pediatrics found.
About 35% of adolescents ages 12 to 14 years report vaping marijuana, compared with 51% of teens ages 15 to 17 years and 54% of young adults ages 18 to 24 years, the data showed. One in four young adults ages 18 to 24 years reported using e-cigarettes, compared with 14% of those ages 15 to 17 years and 3% of those 12 to 14 years, the researchers said.
"Our findings suggest that many adolescents and young adults who use e-cigarettes are vaping cannabis," study co-author Ruoyan Sun told UPI in an email.
February 08, 2022 by None
Synthetic nicotine: Unregulated and increasingly popular
While top tobacco regulators dawdle over the fate of the e-cigarette industry, another class of vape is quietly restocking the market with unregulated, flavored products — and it’s drawing in a growing number of kids.
To users, these vapes are identical. But because of an obscure loophole, they skirt the Food and Drug Administration’s regulatory umbrella. Rather than containing tobacco-derived nicotine, the addictive stimulant found in traditional cigarette and vape products, these vapes have a lab-made version.
February 08, 2022 by cnn.com
E-cigarettes were less effective than gum and other nicotine replacement aids, study says
People using e-cigarettes to quit smoking found them to be less helpful than more traditional smoking cessations aids, a new study found. The study, published Monday in the journal BMJ, analyzed the latest 2017 to 2019 data from the Population Assessment of Tobacco and Health Study, which follows tobacco use among Americans over time. "This is the first time we found e-cigarettes to be less popular than FDA-approved pharmaceutical aids, such as medications or the use of patches, gum, or lozenges," said John P. Pierce, the director for population sciences at the Moores Cancer Center at the University of California, San Diego.
February 07, 2022 by oncnursingnews.com
E-Cigarettes Pose Serious Health Risk for Patients
Nurses have the power to spread the word about e-cigarette risks, according to Tiffany Klein, RN, BSN, Cancer Treatment Centers of America Atlanta.
Klein, who has experience in oncology and currently works on a pulmonology team, recently spoke to Oncology Nursing News® about her experience with electronic smoking and vaping, and how the rise of these activities can affect patients and nurses across various specialties.
February 07, 2022 by filtermag.org
Court Lets Four FDA-Denied Vape Companies Resume Sales, for Now
On February 1, the Eleventh Circuit Court of Appeals granted four nicotine vape manufacturers—Bidi Vapor, Diamond Vapor, Johnny Cooper and Vapor Unlimited—judicial stays on their marketing denial orders (MDOs) issued by the Food and Drug Administration (FDA). The decision means that these producers can continue selling their harm reduction products while the lawsuits remain active.
They followed dozens of other vape companies in taking legal action against the FDA, after the agency denied thousands of products through its new premarket tobacco product application (PMTA) pathway. [...]
January 28, 2022 by news-medical.net
Banning tobacco products leads to a 4% decline in gross sales, finds study
New research in the INFORMS journal Marketing Science shows that doing something positive for public health can be costly. The researchers say that banning tobacco products means retailers may see as much as a 4% decline in gross sales.
"Our results highlight the role of tobacco as a traffic driver to brick-and-mortar stores and demonstrate the unintended microeconomic consequence of tobacco bans. These sales losses occur regardless of whether the ban is voluntary or not."
Pradeep Chintagunta, University of Chicago
January 28, 2022 by journalnow.com
22nd Century begins retail production of very-low-nicotine cigarettes
The cigarettes are being produced at its Mocksville facility, where it has a workforce of 56 employees.
The Buffalo-based manufacturer announced Jan. 18 it plans to launch in March the advertising and distribution of its very-low-nicotine traditional cigarettes in the first major metropolitan market.
January 27, 2022 by journalnow.com
Status quo market share remains trend among top electronic cigarettes
The market-share gap between the top-selling U.S. electronic cigarettes remained at a status-quo stage with top-selling Juul holding about a 4.8-percentage point gap over R.J. Reynolds Vapor Co.’s Vuse. The latest Nielsen analysis of convenience store data, covering the four-week period ending Jan. 15, determined Juul was at 38.1% market share and Vuse at 33.3%. [...] E-cigarette sales overall have slumped since February 2020, when the Food and Drug Administration implemented its latest round of heightened regulations on the products.
January 27, 2022 by medium.com
Michael Bloomberg loves data. Except when he doesn’t.
Michael Bloomberg, the philanthropist and former New York City mayor, made a fortune estimated at $70 billion by selling data, so it’s no wonder that he loves to talk about data and its value.
His foundation, Bloomberg Philanthropies, which says it is “using data to save lives” makes grants to cities to deploy data and evidence. Bloomberg said during his presidential campaign that “data is more important than ever in the era of fake news and alternative facts.” He tweeted: “In God we trust. Everyone else: bring data.” He tweeted, again: “Let science, and good data, and good evidence guide your policy.”